Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling

Molecular and Cellular Biochemistry

Volumn 381, Issue 1-2, 2013, Pages 273-282

  Lu, Liang ^a   Li, Cuixian ^a   Li, Dong ^a   Wang, Ying ^a   Zhou, Chun ^a   Shao, Weiwei ^a   Peng, Jin ^a   You, Yan ^a   Zhang, Xinwen ^a   Shen, Xiaoyan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cryptotanshinone; Malignant gliomas; Proliferation; Signal transducer and activator of transcription 3

Indexed keywords

CRYPTOTANSHINONE; CYCLIN D1; STAT3 PROTEIN; SURVIVIN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; G1 PHASE; GLIOMA; HUMANS; MUTANT PROTEINS; PHENANTHRENES; PHOSPHORYLATION; PHOSPHOTYROSINE; RATS; RNA, SMALL INTERFERING; S PHASE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

SALVIA MILTIORRHIZA;

EID: 84882700957     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1711-x     Document Type: Article

References (33)

1. Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479-489
2. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14:v1-v49
3. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
4. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC (2006) Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973-2001. Neurosurg Focus 20:E1
5. Lo HW (2010) Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets 10:840-848
6. Herbert B Newton (2004) Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: pI3K/Akt/PTEN, mTOR. SHH/PTCH and angiogenesis 4:105-128
7. Stechishin OD, Luchman HA, Ruan Y et al (2013) On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Neuro Oncol 15:198-207
8. Doucette TA, Kong LY, Yang Y et al (2012) Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol 14:1136-1145
9. Heimberger AB, Priebe W (2008) Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers. Recent Pat CNS Drug Discov 3:179-188
10. Carro MS, Lim WK, Alvarez MJ et al (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318-325
11. Huang S (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Cancer Res 13:1362-1366
12. Heimberger AB (2011) The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies. Surg Neurol Int 2:163
13. Ang KP, Tan HK, Selvaraja M et al (2011) Cryptotanshinone attenuates in vitro oxLDL-induced pre-lesional atherosclerotic events. Planta Med 77:1782-1787
14. Jin YC, Kim CW, Kim YM et al (2009) Cryptotanshinone, a lipophilic compound of Salvia miltiorrhiza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur J Pharmacol 614:91-97
15. Tang S, Shen XY, Huang HQ et al (2011) Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-kappaB and MAPK signaling pathways. Inflammation 34:111-118
16. Mei Z, Zhang F, Tao L et al (2009) Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Neu-rosci Lett 452:90-95
17. Park IJ, Kim MJ, Park OJ et al (2012) Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells. Apop-tosis 17:248-257
18. Gong Y, Li Y, Lu Y et al (2011) Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice. Int J Cancer 129:1042-1052
19. Li H, Zhang Q, Chu T et al (2012) Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship. Anticancer Drugs 23:846-855
20. Ye Y, Xu W, Zhong W (2010) Effects of cryptotanshinone on proliferation and apoptosis of Hela cell line of cervical cancer. Zhongguo Zhong Yao Za Zhi 35:118-121
21. Shin DS, Kim HN, Shin KD (2009) Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res 69:193-202
22. Chen W, Luo Y, Liu L et al (2010) Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphoryla-tion. Cancer Prev Res (Phila) 3:1015-1025
23. Bromberg JF, Wrzeszczynska MH, Devgan G et al (1999) Stat3 as an oncogene. Cell 98:295-303
24. Hillion J, Dhara S, Sumter TF et al (2008) The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies? Cancer Res 68:10121-10127
25. Weissenberger J, Priester M, Bernreuther C et al (2010) Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1, 2/STAT3 signaling pathway. Clin Cancer Res 16:5781-5795
26. Pan Y, Bi HC, Zhong GP et al (2008) Pharmacokinetic characterization of hydroxylpropyl-beta-cyclodextrin-included complex of cryptotanshinone, an investigational cardiovascular drug purified from Danshen (Salvia miltiorrhiza). Xenobiotica 38:382-398
27. Zhou J, Wulfkuhle J, Zhang H et al (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 104:16158-16163
28. Rane SG, Reddy EP (2000) Janus kinases: components of multiple signaling pathways. Oncogene 19:5662-5679
29. Don MJ, Liao JF, Lin LY, Chiou WF (2007) Cryptotanshinone inhibits chemotactic migration in macrophages through negative regulation of the PI3K signaling pathway. Br J Pharmacol 151:638-646
30. Cavalla P, Dutto A, Piva R et al (1998) Cyclin D1 expression in gliomas. Acta Neuropathol 95:131-135
31. Yamada Y, Kuroiwa T, Nakagawa T et al (2003) Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg 99:738-745
32. Stacey DW (2003) Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 15:158-163
33. Suzuki A, Hayashida M, Ito T et al (2000) Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16 (INK4a) and Cdk2/cyclin E complex activation. Oncogene 19:3225-3234